EGFR overexpression in canine primary lung cancer: Pathogenetic implications and impact on survival

Veterinary and Comparative Oncology

Volumn 12, Issue 3, 2014, Pages 237-248

  Sabattini, S ^a   Mancini, F R ^a   Marconato, L ^b   Bacci, B ^b   Rossi, F ^b   Vignoli, M ^b   Bettini, G ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Veterinary Clinic dell'Orologio   (Italy)

Author keywords

Dog; EGFR; Lung cancer; Pollution; Prognosis; Tyrosine kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADVERSE EFFECTS; AIR POLLUTION; ANIMAL; ANTHRACOSIS; DOG; DOG DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RISK FACTOR; VETERINARY;

AIR POLLUTION; ANIMALS; ANTHRACOSIS; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; LUNG NEOPLASMS; MALE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK FACTORS;

EID: 84905378090     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/vco.12002     Document Type: Article

References (52)

1. Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC and Grizzle WE. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung. Clinical Cancer Research 2002; 8: 734-744.
2. Grandis JR and Sok JC. Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacology & Therapeutics 2004; 102: 37-46.
3. Merrick DT, Kittelson J, Winterhalder R, Kotantoulas G, Ingeberg S, Keith RL, Kennedy TC, Miller YE, Franklin WA and Hirsch FR. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer. Clinical Cancer Research 2006; 12: 2281-2288.
4. Hirsch FR, Varella-Garcia M and Cappuzzo F. Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer. Oncogene 2009; 28 (Suppl 1): S32-S37.
5. Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D, Wilson R, Kris M and Varmus H. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 13306-13311.
6. Tam IY, Chung LP, Suen WS, Wang E, Wong MC, Ho KK, Lam WK, Chiu SW, Girard L, Minna JD, Gazdar AF and Wong MP. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clinical Cancer Research 2006; 12: 1647-1653.
7. Kulesza P, Ramchandran K and Patel JD. Emerging concepts in the pathology and molecular biology of advanced non-small cell lung cancer. American Journal of Clinical Pathology 2011; 136: 228-238.
8. Withrow SJ. Tumors of the respiratory system - lung cancer. In: Withrow and MacEwen's Small Animal Clinical Oncology. 4th edn., SJ Withrow and DM Vail Eds., Philadelphia, WB Saunders Co, 2007: 517-521.
9. Auerbach O, Hammond EC, Kirman D and Garfinkel L. Effects of cigarette smoking on dogs. Archives of Environmental Health 1970; 21: 754-768.
10. Reif JS and Cohen D. The environmental distribution of canine respiratory tract neoplasms. Archives of Environmental Health 1971; 22: 136-140.
11. Ogilvie GK, Haschek WM, Withrow SJ, Richardson RC, Harvey HJ, Henderson RA, Fowler JD, Norris AM, Tomlinson J and McCaw D. Classification of primary lung tumors in dogs: 210 cases (1975-1985). Journal of the American Veterinary Medical Association 1989; 195: 106-112.
12. Reif JS, Dunn K, Ogilvie GK and Harris CK. Passive smoking and canine lung cancer risk. American Journal of Epidemiology 1992; 135: 234-239.
13. Roza MR and Viegas CA. The dog as a passive smoker: effects of exposure to environmental cigarette smoke on domestic dogs. Nicotine & Tobacco Research 2007; 9: 1171-1176.
14. Bettini G, Morini M, Marconato L, Marcato PS and Zini E. Association between environmental dust exposure and lung cancer in dogs. The Veterinary Journal 2010; 186: 364-369.
15. Ogilvie GK, Weigel RM, Haschek WM, Withrow SJ, Richardson RC, Harvey HJ, Henderson RA, Fowler JD, Norris AM and Tomlinson J. Prognostic factors for tumor remission and survival in dogs after surgery for primary lung tumor: 76 cases (1975-1985). Journal of the American Veterinary Medical Association 1989; 195: 109-112.
16. McNiel EA, Ogilvie GK, Powers BE, Hutchison JM, Salman MD and Withrow SJ. Evaluation of prognostic factors for dogs with primary lung tumors: 67 cases (1985 - 1992). Journal of the American Veterinary Medical Association 1997; 211: 1422-1428.
17. Ramos-Vara JA, Miller MA and Johnson GC. Usefulness of thyroid transcription factor-1 immunohistochemical staining in the differential diagnosis of primary pulmonary tumors of dogs. Veterinary Pathology 2005; 42: 315-320.
18. Bettini G, Marconato L, Morini M and Ferrari F. Thyroid transcription factor-1 immunohistochemistry: diagnostic tool and malignancy marker in canine malignant lung tumours. Veterinary and Comparative Oncology 2008; 7: 28-37.
19. Owen LN. TNM Classification of Tumors in Domestic Animals. World Health Organization, Geneva, 1980.
20. Dungworth DL, Hauser B, Hahn FF, Wilson DW, Haenichen T and Harkema JR. World Health Organization International Histological Classification of Tumors of Domestic Animals - Histological Classification of Tumors of the Respiratory System of Domestic Animals, 2nd Series. Vol VI. Washington, Armed Forces Institute of Pathology, 1999.
21. Shiomitsu K, Johnson CL, Malarkey DE, Pruitt AF and Thrall DE. Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumors. Veterinary and Comparative Oncology 2009; 7: 106-114.
22. Nii A, Nakayama H, Takahashi R and Fujiwara K. Pathology of ten cases of canine primary lung tumor. Nippon Juigaku Zasshi 1985; 47: 811-815.
23. Brodey RS and Craig PH. Primary pulmonary neoplasms in the dog: a review of 29 cases. Journal of the American Veterinary Medical Association 1965; 147: 1628-1643.
24. Wilson DW and Dungworth DL. Tumors of the respiratory tract. In: Tumors in Domestic Animals. 4th edn., DJ Meuten Ed., Ames, Iowa State Press, 2002: 365-399.
25. Polton GA, Brearley MJ, Powell SM and Burton CA. Impact of primary tumour stage on survival in dogs with solitary lung tumours. Journal of Small Animal Practice 2008; 49: 66-71.
26. Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, Clarke CA, Holmberg L, Yong LC, Kolonel LN, Gould MK and West DW. Lung cancer incidence in never smokers. Journal of Clinical Oncology 2007; 25: 472-478.
27. Smith BJ. Pleura, lungs and Mediastinum. In: Canine Anatomy. Philadelphia, Lippincott Williams & Wilkins, 1999: 359-366.
28. Mehta M, Chen LC, Gordon T, Rom W and Tang MS. Particulate matter inhibits DNA repair and enhances mutagenesis. Mutation Research 2008; 657: 116-121.
29. Weissenberg A, Sydlik U, Peuschel H, Schroeder P, Schneider M, Schins RP, Abel J and Unfried K. Reactive oxygen species as mediators of membrane-dependent signaling induced by ultrafine particles. Free Radical Biology and Medicine 2010; 49: 597-605.
30. Hirsch FR, Varella-Garcia M, Bunn PA Jr, Di Maria MV, Veve R, Bremmes RM, Barón AE and Zeng Franklin WA. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. Journal of Clinical Oncology 2003; 21: 3798-3807.
31. Liang Z, Zhang J, Zeng X, Gao J, Wu S and Liu T. Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas. BMC Cancer 2010; 10: 376.
32. Looper JS, Malarkey DE, Ruslander D, Proulx D and Thrall DE. Epidermal growth factor receptor expression in feline oral squamous cell carcinomas. Veterinary and Comparative Oncology 2006; 4: 33-40.
33. Dickinson PJ, Roberts BN, Higgins RJ, Leutenegger CM, Bollen AW, Kass PH and LeCouteur RA. Expression of receptor tyrosine kinases VEGFR-1 (FLT-1), VEGFR-2 (KDR), EGFR-1, PDGFRalpha and c-Met in canine primary brain tumours. Veterinary and Comparative Oncology 2006; 4: 132-140.
34. Gama A, Gärtner F, Alves A and Schmitt F. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues. Research in Veterinary Science 2009; 87: 432-437.
35. Sabattini S, Marconato L, Zoff A, Morini M, Scarpa F, Capitani O and Bettini G. Epidermal growth factor receptor expression is predictive of poor prognosis in feline cutaneous squamous cell carcinoma. Journal of Feline Medicine and Surgery 2010; 12: 760-768.
36. Gillett NA, Stegelmeier BL, Kelly G, Haley PJ and Hahn FF. Expression of epidermal growth factor receptor in plutonium-239-induced lung neoplasms in dogs. Veterinary Pathology 1992; 29: 46-52.
37. Sobol RE, Astarita RW, Hofeditz C, Masui H, Fairshter R, Royston I and Mendelsohn J. Epidermal growth factor receptor expression in human lung carcinomas defined by a monoclonal antibody. Journal of National Cancer Institute 1987; 79: 403-407.
38. Maurizi M, Almadori G, Ferrandina G, Distefano M, Romanini ME, Cadoni G, Benedetti-Panici P, Paludetti G, Scambia G and Mancuso S. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. British Journal of Cancer 1996; 74: 1253-1257.
39. Mellon K, Wright C, Kelly P, Horne CH and Neal DE. Long-term outcome related to epidermal growth factor receptor status in bladder cancer. The Journal of Urology 1995; 153: 919-925.
40. Fischer-Colbrie J, Witt A, Heinzl H, Speiser P, Czerwenka K, Sevelda P and Zeillinger R. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients. Anticancer Research 1997; 17: 613-619.
41. Inada S, Koto T, Futami K, Arima S and Iwashita A. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor). Surgery Today 1999; 29: 493-503.
42. Tateishi M, Ishida T, Mitsudomi T, Kaneko S and Sugimachi K. Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Research 1990; 50: 7077-7080.
43. Nicholson RI, Gee JMW and Harper ME. EGFR and cancer prognosis. European Journal of Cancer 2001; 37: S9-S15.
44. Selvaggi G, Novello S, Torri V, Leonardo E, De Giuli P, Borasio P, Mossetti C, Ardissone F, Lausi P and Scagliotti GV. Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small cell lung cancer. Annals of Oncology 2004; 15: 28-32.
45. Rusch V, Klimstra D, Venkatraman E, Pisters PWT, Langenfeld J and Dmitrovsky E. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clinical Cancer Research 1997; 3: 515-522.
46. Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi H, Angeletti CA, Pingitore R, Pepe S, Basolo F and Bevilacqua G. Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. European Journal of Cancer 1995; 31A: 178-183.
47. Pfieffer P, Clausen PP, Andersen K and Rose C. Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated nonsmall cell lung cancer: an immunohistochemical study on cryosections. Britsh Journal of Cancer 1996; 74: 86-91.
48. Bergkvist GT, Argyle DJ, Morrison L, MacIntyre N, Hayes A and Yool DA. Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC). Veterinary and Comparative Oncology 2011; 9: 106-117.
49. Hirsch FR, Dziadziuszko R, Thatcher N, Mann H, Watkins C, Parums DV, Speake G, Holloway B, Bunn PA Jr and Franklin WA. Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer. Cancer. 2008; 112: 1114-1121.
50. Kraegel SA, Gumerlock PH, Dungworth DL, Oreffo VI and Madewell BR. K-ras activation in non-small cell lung cancer in the dog. Cancer Research 1992; 52: 4724-4727.
51. Griffey SM, Kraegel SA and Madewell BR. Rapid detection of K-ras gene mutations in canine lung cancer using single-strand conformational polymorphism analysis. Carcinogenesis 1998; 19: 959-963.
52. Mounawar M, Mukeria A, Le Calvez F, Hung RJ, Renard H, Cortot A, Bollart C, Zaridze D, Brennan P, Boffetta P, Brambilla E and Hainaut P. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history. Cancer Research 2007; 67: 5667-5672.